Anup Marda
Director of Finance/CFO bei CABALETTA BIO, INC.
Vermögen: 853 000 $ am 31.03.2024
Profil
Anup Marda is currently the Chief Financial & Accounting Officer at Cabaletta Bio, Inc. He previously worked as the Executive Director at US Pharmaceuticals, Inc. from 2012 to 2014 and as the VP, Head-Global Financial Planning & Analysis at Bristol Myers Squibb Co. from 2018 to 2019.
Mr. Marda received his undergraduate degree from the Indian Institute of Technology Bombay and his MBA from Krannert School of Management.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CABALETTA BIO, INC.
0,10% | 01.03.2024 | 50 000 ( 0,10% ) | 853 000 $ | 31.03.2024 |
Aktive Positionen von Anup Marda
Unternehmen | Position | Beginn |
---|---|---|
CABALETTA BIO, INC. | Director of Finance/CFO | 01.01.2019 |
Ehemalige bekannte Positionen von Anup Marda
Unternehmen | Position | Ende |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2019 |
US Pharmaceuticals, Inc.
US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology US Pharmaceuticals, Inc. manufactures and distributes medicines. The private company is based in Seal Beach, CA. | Director/Board Member | 01.01.2014 |
Ausbildung von Anup Marda
Indian Institute of Technology Bombay | Undergraduate Degree |
Krannert School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
CABALETTA BIO, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
US Pharmaceuticals, Inc.
US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology US Pharmaceuticals, Inc. manufactures and distributes medicines. The private company is based in Seal Beach, CA. | Health Technology |